Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
-
Leapfrog Bio announced AACR presentation describing the discovery, characterization, and clinical development plan for lead drug LFB-190.
-
RenaissThera Closes Seed Funding to Drive AI-Powered Therapies for Cardio-Metabolic Diseases
-
Wilmington, Delaware, Transparency Market Research Inc. –, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The global DNA polymerase market (Mercado de la ADN polimerasa) was valued at USD 137.0 Million in 2023...
-
RenaissThera Closes Seed Funding to Drive AI-Powered Therapies for Cardio-Metabolic Diseases
-
aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis
-
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The American Institute of Chemical Engineers (AIChE) celebrated the contributions of the companies and the leaders of BASF Corporation and Celanese...
-
BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and...
-
Lakewood, CO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC: KRTL) announces that its subsidiary, KRTL Biotech Inc., has successfully registered Industria Químico Farmaceutica...
-
IonOpticks and Biognosys announce a long-term supply agreement. Under the agreement, IonOpticks will supply Biognosys with custom chromatography columns.